Conclusion
inflammation, pancreatic head cancer
INFLAMMATION
This study established that circulating inflammation markers ratios, especially FAR, FPR, and FLR, could be used as cost-effective diagnostic biomarkers for early-stage PC that improve the diagnostic accuracy over CA199. The combination of FAR, FPR, FLR, and CA199 was a potentially effective biomarker for distinguishing early -stage PC patients from HC and in differentiating early -stage PC patients from patients with OPT. The combination of FAR, FPR, FLR, and CA199 may be useful as a differential diagnostic marker for patients with pancreatic head cancer.